| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |



From the Department of Cell and Molecular Biology *
Institute, for Neuroscience, Northwestern University Medical School,
Chicago, Illinois; the Program in Cognitive Neuroscience and
Schizophrenia,
Nathan Kline Institute for
Psychiatric Research, Orangeburg, New York; the ICOS
Corporation,
Bothell, Washington; the
Department of Neurological Sciences,§
Rush
Alzheimer's Disease Center, Rush-Presbyterian-St. Luke's Medical
Center, Chicago, Illinois; and the Department of Medical
Biochemistry,¶
Ohio State University College of
Medicine, Columbus, Ohio
Alzheimer's Disease (AD) is a progressive neurodegenerative
disorder involving select neurons of the hippocampus,
neocortex, and other regions of the brain. Markers of end stage
disease include fibrillar lesions, which accumulate
hyperphosphorylated tau protein polymerized into filaments, and
granulovacuolar lesions, which appear primarily within the
hippocampus. The mechanism by which only select populations of neurons
develop these lesions as well as the relationship between them is
unknown. To address these questions, we have turned to AD
tissue to search for enzymes specifically involved in tau
hyperphosphorylation. Recently, we showed that the principal
phosphotransferases associated with AD brain-derived tau filaments are
members of the casein kinase-1 (CK1) family of protein kinases. Here we
report the distribution of three CK1 isoforms (Cki
,
Cki
, and Cki
) in AD and control brains using
immunohistochemistry and Western analysis. In addition to colocalizing
with elements of the fibrillar pathology, CK1 is found within
the matrix of granulovacuolar degeneration bodies. Furthermore,
levels of all CK1 isoforms are elevated in the CA1 region of AD
hippocampus relative to controls, with one isoform,
Cki
, being elevated >30-fold. We propose that
overexpression of this protein kinase family plays a key role in the
hyperphosphorylation of tau and in the formation of AD-related
pathology.
This article has been cited by other articles:
![]() |
D. P. Hanger, H. L. Byers, S. Wray, K.-Y. Leung, M. J. Saxton, A. Seereeram, C. H. Reynolds, M. A. Ward, and B. H. Anderton Novel Phosphorylation Sites in Tau from Alzheimer Brain Support a Role for Casein Kinase 1 in Disease Pathogenesis J. Biol. Chem., August 10, 2007; 282(32): 23645 - 23654. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chergui, P. Svenningsson, and P. Greengard Physiological Role for Casein Kinase 1 in Glutamatergic Synaptic Transmission J. Neurosci., July 13, 2005; 25(28): 6601 - 6609. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, H. Yin, and J. Kuret Casein Kinase 1 Delta Phosphorylates Tau and Disrupts Its Binding to Microtubules J. Biol. Chem., April 16, 2004; 279(16): 15938 - 15945. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kobayashi, K. Tanaka, K. Inoue, and A. Kakizuka Functional ATPase Activity of p97/Valosin-containing Protein (VCP) Is Required for the Quality Control of Endoplasmic Reticulum in Neuronally Differentiated Mammalian PC12 Cells J. Biol. Chem., November 27, 2002; 277(49): 47358 - 47365. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Liu, D. M. Virshup, A. C. Nairn, and P. Greengard Mechanism of Regulation of Casein Kinase I Activity by Group I Metabotropic Glutamate Receptors J. Biol. Chem., November 15, 2002; 277(47): 45393 - 45399. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. King, N. Ghoshal, J. S. Wall, L. I. Binder, and H. Ksiezak-Reding Structural Analysis of Pick's Disease-Derived and in Vitro-Assembled Tau Filaments Am. J. Pathol., April 1, 2001; 158(4): 1481 - 1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Abraha, N Ghoshal, T. Gamblin, V Cryns, R. Berry, J Kuret, and L. Binder C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease J. Cell Sci., January 11, 2000; 113(21): 3737 - 3745. [Abstract] [PDF] |
||||
![]() |
N. Mashhoon, A. J. DeMaggio, V. Tereshko, S. C. Bergmeier, M. Egli, M. F. Hoekstra, and J. Kuret Crystal Structure of a Conformation-selective Casein Kinase-1 Inhibitor J. Biol. Chem., June 23, 2000; 275(26): 20052 - 20060. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |